Armistice Capital »

Argan shares owned by Armistice Capital

Quarter-by-quarter ownership of Argan (AGX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Argan

Tip: Access up to 7 years of quarterly data

All positions including Argan held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argan by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $215k 796 270.05

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Argan

BlackRock
Vanguard Group
Renaissance Technologies
First Trust Advisors
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
State Street Corporation
Invesco
Susquehanna International
Lord, Abbett & Co
Valiant Capital Management
Arrowstreet Capital, Limited Partnership
AltraVue Capital
Value Aligned Research Advisors

View all funds holding Argan